6/18/2012

19 Most Recommended High Yield Large Caps

Large Capitalized High Yields With Buy Or Better Recommendation Researched By Dividend Yield - Stock, Capital, Investment. 952! That’s the number of stocks with a dividend yield over 5 percent, also called High Yields. Those stocks can give you a huge income boost if the dividend payments are sustainable. Let’s take a look at the stocks with the highest recommendation level.

I screened all high yields at the capital markets with a buy or better recommendation and a market capitalization over USD 10 billion. Nineteen stocks remained of which four have a double-digit yield.

Here are my favorite stocks:
(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

Plains All American Pipelines (NYSE:PAA) has a market capitalization of $12.38 billion. The company employs 3,800 people, generates revenues of $34,275.00 million and has a net income of $994.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,530.00 million. Because of these figures, the EBITDA margin is 4.46 percent (operating margin 3.79 percent and the net profit margin finally 2.90 percent). 


Financial Analysis: The total debt representing 33.80 percent of the company’s assets and the total debt in relation to the equity amounts to 95.39 percent. Due to the financial situation, a return on equity of 15.47 percent was realized. Twelve trailing months earnings per share reached a value of $5.01. Last fiscal year, the company paid $3.91 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.31, P/S ratio 0.36 and P/B ratio 2.27. Dividend Yield: 5.45 percent. The beta ratio is 0.49.


Long-Term Stock History Chart Of Plains All Americ... (Click to enlarge)
Long-Term Dividends History of Plains All Americ... (PAA) (Click to enlarge)
Long-Term Dividend Yield History of Plains All Americ... (NYSE: PAA) (Click to enlarge)


Enterprise Products (NYSE:EPD) has a market capitalization of $42.68 billion. The company employs 6,900 people, generates revenues of $44,313.00 million and has a net income of $2,088.30 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,736.30 million. Because of these figures, the EBITDA margin is 8.43 percent (operating margin 6.45 percent and the net profit margin finally 4.71 percent). 


Financial Analysis: The total debt representing 42.58 percent of the company’s assets and the total debt in relation to the equity amounts to 119.94 percent. Due to the financial situation, a return on equity of 17.43 percent was realized. Twelve trailing months earnings per share reached a value of $2.61. Last fiscal year, the company paid $2.44 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.30, P/S ratio 0.96 and P/B ratio 3.51. Dividend Yield: 5.25 percent. The beta ratio is 0.60.


Long-Term Stock History Chart Of Enterprise Produc... (Click to enlarge)
Long-Term Dividends History of Enterprise Produc... (EPD) (Click to enlarge)
Long-Term Dividend Yield History of Enterprise Produc... (NYSE: EPD) (Click to enlarge)


GlaxoSmithKline (NYSE:GSK) has a market capitalization of $111.82 billion. The company employs 97,389 people, generates revenues of $43,038.99 million and has a net income of $8,577.31 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14,470.48 million. Because of these figures, the EBITDA margin is 33.62 percent (operating margin 28.50 percent and the net profit margin finally 19.93 percent). 


Financial Analysis: The total debt representing 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.15. Last fiscal year, the company paid $2.20 in form of dividends to shareholders. 


Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.33, P/S ratio 2.61 and P/B ratio 9.01. Dividend Yield: 5.05 percent. The beta ratio is 0.63.


Long-Term Stock History Chart Of GlaxoSmithKline p... (Click to enlarge)
Long-Term Dividends History of GlaxoSmithKline p... (GSK) (Click to enlarge)
Long-Term Dividend Yield History of GlaxoSmithKline p... (NYSE: GSK) (Click to enlarge)


Take a closer look at the full table of high yield large cap stocks with buy or better recommendation. The average price to earnings ratio (P/E ratio) amounts to 16.13 and forward P/E ratio is 9.61. The dividend yield has a value of 7.91 percent. Price to book ratio is 2.17 and price to sales ratio 1.56. The operating margin amounts to 16.95 percent and the beta ratio is 1.02.

Here is the full table with some fundamentals (TTM):


Related stock ticker symbols:
TEF, FTE, AGNC, STD, CTL, TOT, CIG, E, SLF, ETE, TI, WPZ, MBT, VIP, PAA, VOD, EPD, MT, GSK

Selected Articles:

  
* I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.

If you feel that my work has helped you and you'd like to support my mission to spread investment ideas like honesty, openness, unconditional love, and courage, please make a donation below. I'm very grateful for your support.

Being supported by my readers enables me to give my creative output (articles, pdf free downloads) to the public domain, so it isn't copyrighted. Please share it freely so that others may benefit from it.

Thanks so much for your support. I really appreciate it.

To donate via PayPal, credit card, or e-check, please click the button below:

If you like to receive the Dividend Weekly for free (weekly published E-Book with around 1,000 best dividend paying stocks), please enter your email and verify your adress. Easily unsubscribe at any time.